Anyone who works with software for life sciences R&D has probably heard of the Pistoia Alliance, which counts among its members most of the large pharmaceutical companies. The organisation has lately been working on an app strategy, to help both vendors and customers design and build mobile apps and accompanying cloud-based services to make them more useful and more accessible to their customer base. And conversely making it easier for customers to help guide the way these products are built, in order to solve real problems. The strategy includes the creation of an enterprise app store, which provides an alternative way to deliver apps. Continue reading
Month: August 2012
MolPrime for Android now on Google Play
As of now, version 1.0 of MolPrime for Android is available on Google Play. It’s a free app, so if you have an Android device running on operating system 2.3 or later, you can check it out at your leisure. Continue reading
Presentations from ACS Philadelphia
The 2012 Autumn American Chemical Society meeting is now wrapped up, and I’m back in the office sorting through a prioritised to-do list. I presented two talks, both of which are now available on slideshare. Continue reading
MolPrime for Android: getting close
The Android port of MolPrime is getting very close to being ready for a 1.0 release. The port from iOS (Objective C) to Android (Java) has been underway for some weeks now, and most of the functionality is fully operational. Continue reading
ODDT app adding a Sponsors tab
Version 0.9.7 of the Open Drug Discovery Teams app has been uploaded to the iTunes AppStore, and is awaiting review. The most noticeable difference in this version is that there is now a 4th tab, called Sponsors. This is a feature that is due to the completion of our IndieGoGo campaign, to which a handful of generous supporters expressed their encouragement. As of this version, we can associate sponsors with a topic simply by sending out a specially formatted tweet – a sponsorship acknowledgement is now a special kind of factoid.